{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:26:57Z","timestamp":1787023617629,"version":"build-2736575974"},"reference-count":13,"publisher":"Impact Journals, LLC","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,6,27]]},"DOI":"10.18632\/oncotarget.17978","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T09:48:02Z","timestamp":1495100882000},"page":"43218-43227","source":"Crossref","is-referenced-by-count":21,"title":["VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients"],"prefix":"10.18632","volume":"8","author":[{"given":"Sascha","family":"Kuerti","sequence":"first","affiliation":[{"name":"Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Oliveira-Ferrer","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Milde-Langosch","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schmalfeldt","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Legler","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn","family":"Woelber","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Prieske","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Munich, Munich 81377, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Trillsch","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Munich, Munich 81377, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"3","doi-asserted-by":"publisher","first-page":"17261","DOI":"10.18632\/oncotarget.3746","article-title":"Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome","volume":"6","author":"Pils","year":"2015","journal-title":"Oncotarget"},{"key":"4","first-page":"207","article-title":"E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer","volume":"114","author":"Mahner","year":"2016","journal-title":"Br J Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1158\/1078-0432.CCR-07-1888","article-title":"Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?","volume":"14","author":"Durrant","year":"2008","journal-title":"Clin Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10555-011-9337-5","article-title":"Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer","volume":"31","author":"Pourgholami","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0033-1350713","article-title":"S3-Guideline on diagnostics, therapy and follow-up of malignant ovarian tumours: short version 1.0 - AWMF registration number: 032\/035OL, June 2013","volume":"73","author":"Piso","year":"2013","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"8","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1093\/emboj\/16.13.3898","article-title":"Proteolytic processing regulates receptor specificity and activity of VEGF-C","volume":"16","author":"Alitalo","year":"1997","journal-title":"EMBO J"},{"key":"9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ajpath.2013.12.030","article-title":"Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms","volume":"184","author":"Belotti","year":"2014","journal-title":"Am J Pathol"},{"key":"10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10585-015-9751-0","article-title":"The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer","volume":"32","author":"Morii","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"11","first-page":"dju249","article-title":"Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer","volume":"106","author":"Keeney","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12325-012-0041-9","article-title":"Bevacizumab in the treatment of ovarian cancer","volume":"29","author":"du Bois","year":"2012","journal-title":"Adv Ther"},{"key":"13","first-page":"211","article-title":"Beyond bevacizumab: an outlook to new anti-angiogenics for the treatment of ovarian cancer","volume":"5","author":"Trillsch","year":"2015","journal-title":"Front Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T16:18:13Z","timestamp":1589127493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":13,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2017,6,27]]}},"alternative-id":["17978","28591727"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17978","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}